FDA Clears Abbott’s Modified CGM For Automated Insulin Delivery Integration, Label Expansion

Abbott announced today it plans to integrate its FDA-cleared modified CGMs with insulin pump makers, including Tandem and Insulet, likely later this year.

FreeStyle Libre 2
• Source: Abbott

More from Regulation

More from Policy & Regulation